Feb 3, 2025 · Zantac lawsuits claim Zantac with NDMA-contaminated ranitidine caused people to develop cancer. Sanofi and Pfizer have offered up to $350 million to settle more than 14,000 Zantac lawsuits.

3 days ago · GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. Rare disease...

Feb 21, 2024 · Get the latest Zantac lawsuit updates and learn if you qualify to file your own product liability claim against the maker of Zantac.

Oct 23, 2024 · In a major development for one of the largest pharmaceutical litigations in recent history, GlaxoSmithKline (GSK) has agreed to pay up to $2.2 billion to settle approximately 80,000 state court lawsuits related to claims that its former heartburn medication, Zantac, caused cancer.

Mar 24, 2020 · The Zantac MDL has centralized more than 2,100 lawsuits filed by individuals alleging that they developed cancer as a result of taking brand-name Zantac or generic ranitidine, Zantac’s active ingredient.

4 days ago · PHILADELPHIA — A group of shareholders has filed a putative class action against GSK PLC in the wake of its $2.2 billion settlement of 80,000 Zantac (ranitidine) lawsuits, accusing the drug maker of hiding an internal report suggesting that the popular heartburn drug contained N-nitrosodimethylamine (NMDA), a cancer-causing compound.

This settlement resolves claims from 80,000 plaintiffs nationwide, who alleged that Zantac, a widely-used medication, was linked to causing cancer. This resolution marks a pivotal moment in addressing the accountability of pharmaceutical manufacturers and underscores the collective efforts to uphold justice for affected individuals and their ...

Apr 5, 2022 · Those who took Zantac made with ranitidine and then developed cancer, filed lawsuits after the drug’s makers issued ranitidine and Zantac recalls due to the potential risk of cancer. The Food and Drug Administration found that Zantac’s active ingredient ranitidine contains N-Nitrosodimethylamine (‘NDMA’), a probable human carcinogen.

As of August 5, 2022, plaintiffs have filed several lawsuits in state courts against the makers and sellers of Zantac. Plaintiffs have also filed more than 2,000 cases in federal, multi-district litigation (MDL) court. The first federal court trial is tentatively scheduled to begin in October 2022, while the state court cases may start sooner.

February 1, 2022: A Zantac lawsuit has been filed in 2,000+ cases. Tens of thousands of other Zantac claims have been preserved through an agreement with the filing of a Zantac lawsuit with defense lawyers and the MDL judge.